- Home
- TRUG vs BCLI Comparison
TRUG vs BCLI Comparison
Compare TRUG & BCLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRUG
- BCLI
- Stock Information
- Founded
- TRUG 1983
- BCLI 2000
- Country
- TRUG United States
- BCLI United States
- Employees
- TRUG N/A
- BCLI N/A
- Industry
- TRUG
- BCLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TRUG
- BCLI Health Care
- Exchange
- TRUG NYSE
- BCLI Nasdaq
- Market Cap
- TRUG 6.4M
- BCLI 6.4M
- IPO Year
- TRUG N/A
- BCLI N/A
- Fundamental
- Price
- TRUG $0.48
- BCLI $1.23
- Analyst Decision
- TRUG
- BCLI Strong Buy
- Analyst Count
- TRUG 0
- BCLI 1
- Target Price
- TRUG N/A
- BCLI $30.00
- AVG Volume (30 Days)
- TRUG 360.0K
- BCLI 118.2K
- Earning Date
- TRUG 11-29-2024
- BCLI 11-14-2024
- Dividend Yield
- TRUG N/A
- BCLI N/A
- EPS Growth
- TRUG N/A
- BCLI N/A
- EPS
- TRUG N/A
- BCLI N/A
- Revenue
- TRUG $21,917,131.00
- BCLI N/A
- Revenue This Year
- TRUG N/A
- BCLI N/A
- Revenue Next Year
- TRUG N/A
- BCLI N/A
- P/E Ratio
- TRUG N/A
- BCLI N/A
- Revenue Growth
- TRUG N/A
- BCLI N/A
- 52 Week Low
- TRUG $0.35
- BCLI $1.05
- 52 Week High
- TRUG $11.82
- BCLI $11.85
- Technical
- Relative Strength Index (RSI)
- TRUG 32.62
- BCLI 26.15
- Support Level
- TRUG $0.35
- BCLI $1.05
- Resistance Level
- TRUG $0.58
- BCLI $1.95
- Average True Range (ATR)
- TRUG 0.09
- BCLI 0.20
- MACD
- TRUG 0.00
- BCLI 0.01
- Stochastic Oscillator
- TRUG 39.21
- BCLI 21.05
About TRUG TRUGOLF HOLDINGS INC
TruGolf Holdings Inc is a indoor golf gaming solutions company. It has built video games ("Links"), innovative hardware solutions, and an all-new e-sports platform to connect golfers around the world with E6 CONNECT.
About BCLI Brainstorm Cell Therapeutics Inc.
Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.